Cargando…

The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience

SIMPLE SUMMARY: High body mass index (BMI) is correlated with an increased production of hormones (estrogens, insulin, testosterone, leptin), and pro-inflammatory cytokines, which have been associated with breast cancer (BC) risk and recurrence. Regular physical activity (PA) decreases BMI and blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pistelli, Mirco, Natalucci, Valentina, Scortichini, Laura, Agostinelli, Veronica, Lenci, Edoardo, Crocetti, Sonia, Merloni, Filippo, Bastianelli, Lucia, Taus, Marina, Fumelli, Daniele, Giulietti, Gloria, Cola, Claudia, Capecci, Marianna, Serrani, Roberta, Ceravolo, Maria Gabriella, Ricci, Maurizio, Nicolai, Albano, Barbieri, Elena, Nicolai, Giulia, Ballatore, Zelmira, Savini, Agnese, Berardi, Rossana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583345/ https://www.ncbi.nlm.nih.gov/pubmed/34771702 http://dx.doi.org/10.3390/cancers13215539

Ejemplares similares

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2020)

A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study
por: Natalucci, Valentina, et al.
Publicado: (2021)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Role of maspin in cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

1757P Training and information during COVID-19 pandemic: The masterpiece in young oncologists
por: Ranallo, N., et al.
Publicado: (2020)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
por: Agostinelli, Veronica, et al.
Publicado: (2023)

Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase
por: Merloni, Filippo, et al.
Publicado: (2019)

Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Correction to: Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
por: Pistelli, Mirco, et al.
Publicado: (2014)

1684P Scientia Potentia Est: How the Italian world of oncology changes in the COVID-19 pandemic
por: Ballatore, Z., et al.
Publicado: (2020)

Cancer patient perspective in the arena of COVID‐19 pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2021)

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
por: Pistelli, Mirco, et al.
Publicado: (2015)

Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type
por: Maccaroni, Elena, et al.
Publicado: (2021)

Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
por: Berardi, Rossana, et al.
Publicado: (2016)

A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC
por: Cantini, Luca, et al.
Publicado: (2021)

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
por: Berardi, Rossana, et al.
Publicado: (2016)

Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows
por: Torniai, Mariangela, et al.
Publicado: (2022)

Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer
por: Pecci, Federica, et al.
Publicado: (2021)

BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
por: Maccaroni, Elena, et al.
Publicado: (2021)

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
por: Berardi, Rossana, et al.
Publicado: (2010)

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
por: Berardi, Rossana, et al.
Publicado: (2015)

Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report
por: Ballatore, Z., et al.
Publicado: (2016)

1699P COVID-19 pandemic: Patients’ perspective during cancer treatment
por: Merloni, F., et al.
Publicado: (2020)

Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing
por: Giampieri, Riccardo, et al.
Publicado: (2020)

Managing hyponatremia in lung cancer: latest evidence and clinical implications
por: Fiordoliva, Ilaria, et al.
Publicado: (2017)

1609P COVID-19 outbreak repercussions on breast cancer diagnoses and access to treatment: Preliminary data from the COVID-DELAY study
por: Berardi, R., et al.
Publicado: (2021)

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management
por: Berardi, Rossana, et al.
Publicado: (2020)

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management
por: Mentrasti, Giulia, et al.
Publicado: (2020)

Systemic treatment for lung carcinoids: from bench to bedside
por: Torniai, Mariangela, et al.
Publicado: (2019)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2017)

New Insights into Hormonal Therapies in Uterine Sarcomas
por: Maccaroni, Elena, et al.
Publicado: (2022)

Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer
por: Bittoni, Alessandro, et al.
Publicado: (2021)

SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
por: Giugliano, Federica, et al.
Publicado: (2022)

The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
por: Diotallevi, Federico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0d5mupf6pgf871pim69d47bg4